MPHOSPH6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.021600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.260800E-01
Normal-vs-Stage2
9.328800E-01
Normal-vs-Stage3
3.239600E-01
Normal-vs-Stage4
9.915000E-01
Stage1-vs-Stage2
2.934200E-01
Stage1-vs-Stage3
7.559200E-01
Stage1-vs-Stage4
3.222400E-01
Stage2-vs-Stage3
2.471000E-01
Stage2-vs-Stage4
9.324200E-01
Stage3-vs-Stage4
3.651000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.746000E-01
Normal-vs-AfricanAmerican
8.335600E-01
Normal-vs-Asian
9.615600E-01
Caucasian-vs-AfricanAmerican
9.639600E-01
Caucasian-vs-Asian
8.707800E-01
AfricanAmerican-vs-Asian
9.546400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.099800E-01
Normal-vs-Female
9.688800E-01
Male-vs-Female
2.853000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.408000E-01
Normal-vs-Age(41-60Yrs)
7.477000E-01
Normal-vs-Age(61-80Yrs)
7.175800E-01
Normal-vs-Age(81-100Yrs)
9.009200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.455800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.047200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.487200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.663870E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.729800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.701800E-01
Normal-vs-Daily Drinker
6.353000E-01
Normal-vs-Weekly Drinker
4.874400E-01
Normal-vs-Occasional Drinker
3.171400E-01
Normal-vs-Social Drinker
7.106600E-01
Non Drinker-vs-Daily Drinker
9.733000E-01
Non Drinker-vs-Weekly Drinker
8.765000E-01
Non Drinker-vs-Occasional Drinker
9.324400E-03
Non Drinker-vs-Social Drinker
7.830400E-01
Daily Drinker-vs-Weekly Drinker
8.977400E-01
Daily Drinker-vs-Occasional Drinker
8.959000E-03
Daily Drinker-vs-Social Drinker
7.545000E-01
Weekly Drinker-vs-Occasional Drinker
6.857400E-03
Weekly Drinker-vs-Social Drinker
6.411400E-01
Occasional Drinker-vs-Social Drinker
2.095800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.680000E-01
Normal-vs-Grade 2
7.638000E-01
Normal-vs-Grade 3
4.278800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.252000E-02
Grade 1-vs-Grade 3
7.102200E-02
Grade 1-vs-Grade 4
7.680000E-01
Grade 2-vs-Grade 3
5.482000E-01
Grade 2-vs-Grade 4
7.638000E-01
Grade 3-vs-Grade 4
4.278800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.770000E-01
Normal-vs-NonDiabetic
8.901800E-01
Diabetic-vs-NonDiabetic
6.065200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.727000E-01
Normal-vs-NoPancreatitis
9.250200E-01
Pancreatitis-vs-NoPancreatitis
3.511800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.422000E-01
Normal-vs-N1
9.263000E-01
N0-vs-N1
9.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.272600E-01
Normal-vs-TP53-NonMutant
3.140600E-01
TP53-Mutant-vs-TP53-NonMutant
1.97964999999467E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
